RASSF1A inhibits epithelial–mesenchymal transition of gastric cancer cells by downregulating P‐JNK

Yuling Bin,Wenbing Deng,Hongsai Hu,Qiong Zeng,Juan Chen,Yanqing Xu,Yong Dai,Aijun Liao,Weisheng Xiao
DOI: https://doi.org/10.1002/cbin.11958
IF: 4.473
2022-11-22
Cell Biology International
Abstract:Gastric cancer (GC) is one of the most common gastrointestinal tumors. In this study, we assessed the biological role of Ras association domain family 1 isoform A (RASSF1A) in GC cells. Expressions of RASSF1A and the relationship of RASSF1A with epithelial–mesenchymal transformation (EMT)‐related proteins were assessed in five cell lines using Western blot. GC cells with RASSF1A overexpression were used to study sensitivity to cisplatin, migration, invasion, and the expression of EMT‐associated biomarkers. GC cells showed profound downregulation of RASSF1A expression compared with normal human gastric mucosal cells. High RASSF1A expression was associated with increased overall survival. Overexpression of RASSF1A regulates GC cells activity and the expression of EMT‐associated biomarkers. RASSF1A regulates E‐cadherin and Vimentin through P‐JNK pathway. Our results revealed that RASSF1A can inhibit the proliferation, migration, and invasion of GC cells via E‐cadherin. Our study provides insights for further research on GC.
cell biology
What problem does this paper attempt to address?